Low frequency of side effects following an incidental 25 times concentrated dose of yellow fever vaccine
In August/1999, a group of 14 adults from the staff of a private hospital in Contagem -- Minas Gerais State, Brazil, received unintentionally a 25 times concentrated dose of the 17-DD yellow fever vaccine (Bio-Manguinhos), due to a mistake at the reconstitution step. All patients were clinically and...
| Published in: | Revista da Sociedade Brasileira de Medicina Tropical |
|---|---|
| Main Authors: | Ana Rabello, Marcela Orsini, Jolande Disch, Tânia Marcial, Maria da Luz F. Leal, Marcos da Silva Freire, Anna M. Yoshida Yamamura, Angelo Viana |
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
2002-04-01
|
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822002000200008&tlng=en |
Similar Items
The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01)
by: Ricardo Ishak, et al.
Published: (1990-09-01)
Yellow fever
by: Prata Aluízio
Published: (2000-01-01)
by: Prata Aluízio
Published: (2000-01-01)
What Constitutes Protective Immunity Following Yellow Fever Vaccination?
by: Jolynne Mokaya, et al.
Published: (2021-06-01)
by: Jolynne Mokaya, et al.
Published: (2021-06-01)
Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
by: Fredy Brice Simo Nemg, et al.
Published: (2022-04-01)
by: Fredy Brice Simo Nemg, et al.
Published: (2022-04-01)
Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil
by: Max McClure, et al.
Published: (2025-01-01)
by: Max McClure, et al.
Published: (2025-01-01)
The COVID-19 Impact on the Trends in Yellow Fever and Lassa Fever Infections in Nigeria
by: Nnennaya U. Opara, et al.
Published: (2022-11-01)
by: Nnennaya U. Opara, et al.
Published: (2022-11-01)
Experimental Yellow Fever in Squirrel Monkey: Characterization of Liver In Situ Immune Response
by: Milene S. Ferreira, et al.
Published: (2023-02-01)
by: Milene S. Ferreira, et al.
Published: (2023-02-01)
Development of inactivated cultural yellow fever vaccine
by: A. P. Ivanov, et al.
Published: (2020-09-01)
by: A. P. Ivanov, et al.
Published: (2020-09-01)
Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species
by: Nayara Ferreira de Paula, et al.
Published: (2025-04-01)
by: Nayara Ferreira de Paula, et al.
Published: (2025-04-01)
Development and validation of RT-LAMP for detecting yellow fever virus in non-human primates samples from Brazil
by: Sabrina F. Cardoso, et al.
Published: (2024-09-01)
by: Sabrina F. Cardoso, et al.
Published: (2024-09-01)
Yellow fever vaccination: should India have more centres?
by: Vikas Bhatia, et al.
Published: (2015-01-01)
by: Vikas Bhatia, et al.
Published: (2015-01-01)
Vaccination against yellow fever in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-10-01)
by: B. S. Belov, et al.
Published: (2019-10-01)
Wild-Type Yellow Fever Virus RNA in Cerebrospinal Fluid of Child
by: Paula E.S. Marinho, et al.
Published: (2019-08-01)
by: Paula E.S. Marinho, et al.
Published: (2019-08-01)
Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report
by: Lev Volkov, et al.
Published: (2020-02-01)
by: Lev Volkov, et al.
Published: (2020-02-01)
Wild-type Yellow fever virus in cerebrospinal fluid from fatal cases in Brazil, 2018
by: Izabela Mauricio de Rezende, et al.
Published: (2022-09-01)
by: Izabela Mauricio de Rezende, et al.
Published: (2022-09-01)
To vaccinate or let it be – current recommendations and the reality about yellow fever vaccination
by: Silja Bühler, et al.
Published: (2014-12-01)
by: Silja Bühler, et al.
Published: (2014-12-01)
Advanced Laboratory Methods for Detecting Yellow Fever Pathogen
by: E. I. Krivosheina, et al.
Published: (2021-07-01)
by: E. I. Krivosheina, et al.
Published: (2021-07-01)
Travel pattern and profile of clients using online registration system and mobile accessibility for vaccination in a newly established yellow fever vaccination clinic at AIIMS Patna, India
by: Dhananjay Kumar, et al.
Published: (2017-01-01)
by: Dhananjay Kumar, et al.
Published: (2017-01-01)
Kidney involvement in yellow fever: a review
by: Renata Lima Lopes, et al.
by: Renata Lima Lopes, et al.
Yellow Fever Virus Vaccine Reduces T Cell Receptor Signaling and the Levels of Phosphatase PTPRE In Vivo
by: Jinhua Xiang, et al.
Published: (2020-06-01)
by: Jinhua Xiang, et al.
Published: (2020-06-01)
Ensuring the Safety of Yellow Fever Vaccination in Travelers—The Experience at a Large U.S. Academic Medical Center in Colorado
by: Mehdi Bandali, et al.
Published: (2020-07-01)
by: Mehdi Bandali, et al.
Published: (2020-07-01)
YELLOW ALERT: Persistent Yellow Fever Virus Circulation among Non-Human Primates in Urban Areas of Minas Gerais State, Brazil (2021–2023)
by: Gabriela F. Garcia-Oliveira, et al.
Published: (2023-12-01)
by: Gabriela F. Garcia-Oliveira, et al.
Published: (2023-12-01)
Oral Susceptibility to Yellow Fever Virus of Aedes aegypti from Brazil
by: Ricardo Lourenço-de-Oliveira, et al.
Published: (2002-04-01)
by: Ricardo Lourenço-de-Oliveira, et al.
Published: (2002-04-01)
Yellow Fever Outbreak in Brazil: A crucial time for epidemiologic surveillance
by: Priscila Carminati Siqueira, et al.
Published: (2019-04-01)
by: Priscila Carminati Siqueira, et al.
Published: (2019-04-01)
Yellow Fever in Nigeria: A Review of Past, Current, and Future Strides
by: Anyebe B. Onoja, et al.
Published: (2022-10-01)
by: Anyebe B. Onoja, et al.
Published: (2022-10-01)
Current Trends of Yellow Fever in Nigeria: Challenges and Prospects
by: Abdulkadir B., et al.
Published: (2019-12-01)
by: Abdulkadir B., et al.
Published: (2019-12-01)
“Magic Portraits Drawn by the Sun”: New Orleans, Yellow Fever, and the sense(s) of death in Josh Russell’s Yellow Jack
by: Owen Robinson
Published: (2012-01-01)
by: Owen Robinson
Published: (2012-01-01)
The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences
by: Clarissa de Castro Ferreira, et al.
Published: (2018-01-01)
by: Clarissa de Castro Ferreira, et al.
Published: (2018-01-01)
Herpes Infections in Suspected Cases of Yellow Fever in the Democratic Republic of the Congo
by: Sheila Makiala-Mandanda, et al.
Published: (2021-08-01)
by: Sheila Makiala-Mandanda, et al.
Published: (2021-08-01)
Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults
by: Karina Takesaki Miyaji, et al.
by: Karina Takesaki Miyaji, et al.
Commerce, conflict, and contamination: yellow fever in early-independence Veracruz in the US imaginary, 1821-1848
by: Beau D.J. Gaitors
by: Beau D.J. Gaitors
Analysis of MLKL, RIP1 and RIP3 Immunostaining Markers in Human Liver Tissue from Fatal Yellow Fever Cases: Insights into Necroptosis
by: Vanessa do Socorro Cabral Miranda, et al.
Published: (2024-12-01)
by: Vanessa do Socorro Cabral Miranda, et al.
Published: (2024-12-01)
Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects
by: Elena Gianchecchi, et al.
Published: (2022-02-01)
by: Elena Gianchecchi, et al.
Published: (2022-02-01)
Changing epidemiology of yellow fever virus in Oyo State, Nigeria
by: Bassey Enya Bassey, et al.
Published: (2022-03-01)
by: Bassey Enya Bassey, et al.
Published: (2022-03-01)
Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice
by: Ana Carolina dos Reis Albuquerque Cajaraville, et al.
Published: (2022-12-01)
by: Ana Carolina dos Reis Albuquerque Cajaraville, et al.
Published: (2022-12-01)
Yellow fever in Putumayo, Colombia, 2024
by: Ivan Camilo Sanchez-Rojas, et al.
Published: (2025-04-01)
by: Ivan Camilo Sanchez-Rojas, et al.
Published: (2025-04-01)
Molecular Characterization of Circulating Yellow Fever Viruses from Outbreak in Ghana, 2021–2022
by: Joseph Humphrey Kofi Bonney, et al.
Published: (2023-09-01)
by: Joseph Humphrey Kofi Bonney, et al.
Published: (2023-09-01)
Continuous Circulation of Yellow Fever among Rural Populations in the Central African Republic
by: Huguette SIMO TCHETGNA, et al.
Published: (2022-09-01)
by: Huguette SIMO TCHETGNA, et al.
Published: (2022-09-01)
Descriptive Characterization of Suspected Yellow Fever Cases in Kano state, Nigeria, 2015-2018
by: Usman Yahya Umar, et al.
Published: (2021-01-01)
by: Usman Yahya Umar, et al.
Published: (2021-01-01)
Municipalities of higher vulnerability to Sylvatic Yellow Fever occurrence in the São Paulo State, Brazil
by: Eduardo Stramandinoli Moreno, et al.
Published: (2011-12-01)
by: Eduardo Stramandinoli Moreno, et al.
Published: (2011-12-01)
Similar Items
-
The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01) -
Yellow fever
by: Prata Aluízio
Published: (2000-01-01) -
What Constitutes Protective Immunity Following Yellow Fever Vaccination?
by: Jolynne Mokaya, et al.
Published: (2021-06-01) -
Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
by: Fredy Brice Simo Nemg, et al.
Published: (2022-04-01) -
Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil
by: Max McClure, et al.
Published: (2025-01-01)
